Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F66M2
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,925
Award facts
- Contract value 100% obligated
- $19,925.42 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $19,925.42 to AmerisourceBergen Drug Corp (a subsidiary of Cencora, Inc.) on January 23, 2026, for the supply of DUPIXENT 300 MG/2 ML PEN 2ML. The contract is a firm fixed-price delivery order with an ultimate completion date of January 26, 2026, and will be performed at the awardee's facility in Conshohocken, Pennsylvania. This award was made on a non-set-aside, fully competitive basis and represents a task order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical.
This delivery order falls under AmerisourceBergen's comprehensive $999,999,999.00 indefinite delivery contract with DLA Troop Support Medical (designated SPE2DX), which extends through December 2026 and serves as a global pharmaceutical support vehicle for military healthcare programs. The contract vehicle enables the company to supply a broad range of pharmaceutical products and medical supplies to support Defense Health Agency operations, U.S. Coast Guard medical needs, and other government healthcare systems. DUPIXENT is a specialty biologic medication used for treating atopic dermatitis, eosinophilic esophagitis, and asthma, making this order consistent with AmerisourceBergen's portfolio of delivering critical therapeutic medications across multiple medical domains to federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F66M2?
SPE2DR26F66M2 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 23, 2026.
How much is contract SPE2DR26F66M2 worth?
The government has obligated $19,925 on SPE2DR26F66M2.
Is contract SPE2DR26F66M2 an order under another contract?
Yes. SPE2DR26F66M2 is a delivery order under SPE2DR25D3303, an indefinite delivery contract.
Was contract SPE2DR26F66M2 competed?
The extent of competition for SPE2DR26F66M2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award